Cilostazol in a Child With Moyamoya Disease.

J Child NeurolJan 8, 2026 (epub)

Alizah A Patterson, Sarah K D Vogel, April Sharp et al.

✦ AI-curated · Sources linked

Case in brief

A 9-year-old girl with moyamoya disease was diagnosed after a large right middle cerebral artery stroke. Following pial synangiosis, she developed frequent transient episodes of dysarthria and left-sided drooling. The episodes persisted despite trials of antiseizure medications and blood pressure augmentation, then abated after cilostazol was added. When episodes recurred, they again subsided after the cilostazol dose was adjusted.

What made this case unusual

The report describes cilostazol use for recurrent transient neurologic events in a child with moyamoya after pial synangiosis, an area where pediatric safety and efficacy were stated to be unknown.

Diagnostic / clinical pearl

In this case, recurrent transient neurologic events after pial synangiosis abated with cilostazol and again subsided after dose adjustment; the report does not establish efficacy or safety in other children.

Why it matters

The case highlights the limited evidence for nonsurgical interventions in pediatric moyamoya and the need for further investigation of cilostazol.

Source

Published in J Child Neurol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.